Patent Yard Sign in
European application, no grantEurope

Novel sertraline hydrochloride polymorph, processes for preparing them, compositions containing them and methods of using them

EP 1774965 A2 · Applicant: Teva Pharmaceutical Industries Ltd

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 21, 2000 and never granted as a European patent. Had it been granted, its 20-year term would have ended December 21, 2020.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by June 21, 2026.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledDecember 21, 2000
PublishedApril 18, 2007
GrantedNever granted
Term endedDecember 21, 2020
Application numberEP 07001704
Classification (CPC)C07C211/42

Timeline

Timeline From EPO dates

2001200320052007200920112013201520172019Application filedDec 21, 2000PublishedApril 18, 2007Term endedDec 21, 2020

Sources & verification